首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

疫苗輸送裝置市場規模、佔有率和成長分析（按裝置、給藥途徑、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900062

疫苗輸送裝置市場規模、佔有率和成長分析（按裝置、給藥途徑、最終用戶和地區分類）－2026-2033年產業預測

Vaccine Delivery Devices Market Size, Share, and Growth Analysis, By Type of Device (Needle-Free Injection Systems, Oral Delivery Systems), By Route of Administration, By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，疫苗輸送設備市場規模將達到 73.3 億美元，到 2025 年將達到 79.4 億美元，到 2033 年將達到 150.2 億美元，在預測期（2026-2033 年）內，複合年成長率為 8.3%。

疫苗接種活動的增加以及對高效接種解決方案的需求推動了疫苗接種器材市場強勁成長。主要促進因素包括疫苗接種計劃的擴展、針頭技術的進步以及預防醫學意識的提高。在儲存和運輸過程中，尤其是在低溫運輸物流方面，維持疫苗品質是關注的重點。接種器材的創新旨在確保疫苗的妥善儲存，尤其是在冷藏設施有限的地區。溫度穩定的配方和包裝的開發提高了偏遠地區疫苗的可及性。此外，自毀式注射器、安全針頭和預填充系統的廣泛應用有助於安全且準確地接種疫苗。雖然北美和歐洲目前佔據市場主導地位，但亞太地區展現出巨大的成長潛力，凸顯了對創新且經濟高效的解決方案的需求。

疫苗接種設備市場促進因素

感染疾病流行，導致疫苗需求顯著成長，這主要得益於旨在根除可預防疾病的全球衛生舉措。疫苗需求的成長凸顯了開發高效能疫苗接種裝置的重要性，這些裝置在促進適當免疫方面發揮關鍵作用。隨著醫療機構努力提高疫苗接種率並改善公共衛生狀況，對創新可靠的接種機制的關注變得至關重要。因此，由於需要改善全球人口的疫苗接種方式，疫苗接種裝置市場正經歷需求激增。

疫苗接種設備市場的限制

創新疫苗接種設備的研發和生產通常需要大量的研發投入。這些成本最終可能會轉嫁給最終用戶，例如醫療服務提供者和患者，並可能阻礙這些設備的廣泛應用，尤其是在資源匱乏的地區。這種經濟負擔可能會使醫療機構不願採用先進技術，從而限制了有效疫苗接種方案的普及，並阻礙了旨在提高疫苗接種率的公共衛生措施的進展。因此，在某些地區，這些尖端設備的潛在益處可能無法充分發揮。

疫苗接種設備市場趨勢

疫苗接種設備市場正經歷著向無針接種系統創新發展的顯著轉變，旨在提高患者的舒適度和依從性。諸如噴射注射器、微針貼片和鼻噴劑等替代接種方式的興起，旨在解決患者對針頭的恐懼，同時簡化疫苗接種流程。這些先進技術不僅最大限度地降低了針刺傷的風險，而且有望提高疫苗的穩定性和有效性。隨著醫療機構致力於改善整體疫苗接種體驗並擴大疫苗覆蓋範圍，市場對這些創新解決方案的需求持續成長，這代表著市場正在發生變革性變化。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Becton Dickinson & Company（USA）
Bioject Medical Technologies, Inc.（USA）
Inovio Pharmaceuticals, Inc.（USA）
PharmaJet（USA）
Vaxxas（Australia）
Gerresheimer AG（Germany）
SCHOTT AG（Germany）
Corium International, Inc.（USA）
3M（USA）
West Pharmaceutical Services, Inc.（USA）
Terumo Corporation（Japan）
B. Braun Melsungen AG（Germany）
Smiths Medical（UK）
Medtronic（Ireland）
Sanofi Pasteur（France）
Novartis AG（Switzerland）
Pfizer Inc.（USA）
GlaxoSmithKline plc（UK）
Merck & Co., Inc.（USA）
Johnson & Johnson（USA）

結論與建議

簡介目錄

Product Code: SQMIG35B2152

Vaccine Delivery Devices Market size was valued at USD 7.33 Billion in 2024 and is poised to grow from USD 7.94 Billion in 2025 to USD 15.02 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The vaccine delivery devices market is experiencing robust growth driven by heightened vaccination initiatives and the demand for effective administration solutions. Key catalysts include the expansion of immunization programs, advancements in needle technologies, and a growing awareness of preventive healthcare. Maintaining vaccine integrity during storage and transport, particularly through cold chain logistics, is a critical focus area. Innovations in delivery devices are designed to ensure proper conditions for vaccines, especially in areas with limited refrigeration access. Developments in temperature-stable formulations and packaging enhance vaccine availability in remote regions. Additionally, the rise of auto-disable syringes, safety needles, and prefilled systems promotes safe and accurate delivery. While North America and Europe lead the market, Asia-Pacific shows significant growth potential, emphasizing the need for innovative and cost-effective solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vaccine Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vaccine Delivery Devices Market Segments Analysis

Global Vaccine Delivery Devices Market is segmented by Type of Device, Route of Administration, End Users and region. Based on Type of Device, the market is segmented into Needle-Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches and Microinjectors. Based on Route of Administration, the market is segmented into Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination and Other Vaccinations. Based on End Users, the market is segmented into Hospitals, Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Vaccine Delivery Devices Market

The increasing prevalence of infectious diseases has significantly amplified the demand for vaccines, particularly in the context of global health initiatives aimed at eradicating preventable illnesses. This growing need for vaccinations underscores the importance of developing efficient and effective vaccine delivery devices, which play a crucial role in facilitating proper immunization. As healthcare providers strive to enhance vaccination rates and improve public health outcomes, the focus on innovative and reliable delivery mechanisms becomes paramount. Consequently, the Vaccine Delivery Devices market is experiencing a surge in demand, driven by the necessity for improved methods of administering vaccines to populations worldwide.

Restraints in the Vaccine Delivery Devices Market

The development and production of innovative vaccine delivery devices often require significant investment in research and development. Such expenses may ultimately be transferred to end-users, such as healthcare providers and patients, which could hinder the broader acceptance and utilization of these devices, especially in areas with limited resources. This financial burden may discourage healthcare facilities from adopting advanced technologies, restricting access to effective immunization solutions and impeding progress in public health initiatives aimed at improving vaccination rates. As a result, the potential benefits of these cutting-edge devices may not be fully realized in certain regions.

Market Trends of the Vaccine Delivery Devices Market

The Vaccine Delivery Devices market is experiencing a notable shift towards innovations in needle-free delivery systems, which are increasingly being embraced to enhance patient comfort and compliance. The rise of alternative delivery methods, including jet injectors, microneedle patches, and nasal sprays, is addressing concerns related to needle aversion while aiming to streamline vaccination processes. These advanced technologies not only minimize the risk of needle-stick injuries but also promise improved vaccine stability and efficacy. As healthcare providers focus on enhancing the overall vaccination experience and increasing accessibility, the demand for these innovative solutions continues to grow, signaling a transformative trend in the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis
Technology Analysis

Global Vaccine Delivery Devices Market Size by Type of Device & CAGR (2026-2033)

Market Overview
Needle-Free Injection Systems
Oral Delivery Systems
Nasal Delivery Systems
Jet Injectors
Microneedle Patches
Microinjectors

Global Vaccine Delivery Devices Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Other Vaccinations

Global Vaccine Delivery Devices Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Other End Users

Global Vaccine Delivery Devices Market Size & CAGR (2026-2033)

North America (Type of Device, Route of Administration, End Users)
- US
- Canada
Europe (Type of Device, Route of Administration, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type of Device, Route of Administration, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type of Device, Route of Administration, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Type of Device, Route of Administration, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Becton Dickinson & Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioject Medical Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inovio Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PharmaJet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vaxxas (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SCHOTT AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corium International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi Pasteur (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments